Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a Phase II study
在一项 II 期研究中,HIV 整合酶抑制剂 raltegravir 对治疗选择有限的患者具有长期疗效和安全性
期刊:Jaids-Journal of Acquired Immune Deficiency Syndromes
影响因子:2.2
doi:10.1097/qai.0b013e3181c9c967
Gatell, Jose M; Katlama, Christine; Grinsztejn, Beatriz; Eron, Joseph J; Lazzarin, Adriano; Vittecoq, Daniel; Gonzalez, Charles J; Danovich, Robert M; Wan, Hong; Zhao, Jing; Meibohm, Anne R; Strohmaier, Kim M; Harvey, Charlotte M; Isaacs, Robin D; Nguyen, Bach-Yen T